Literature DB >> 10067990

Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.

A Das1, P G McGuire, C Eriqat, R R Ober, E DeJuan, G A Williams, A McLamore, J Biswas, D W Johnson.   

Abstract

PURPOSE: Retinal neovascularization is one of the leading causes of blindness. A crucial event in this process is the remodeling and penetration of the capillary basement membrane by migrating endothelial cells. This process requires proteolysis of basement membrane components by a variety of proteinases. The objective of the present study was to determine the expression of proteinases in human retinal tissues showing active neovascularization.
METHODS: Epiretinal neovascular membranes surgically removed from patients with proliferative diabetic retinopathy were analyzed by zymography, and the types and amounts of proteinases present in the tissues were determined. Retinas from nondiabetic donor eyes served as control specimens.
RESULTS: Both the high- (54 kDa) and low- (33 kDa) molecular-weight forms of urokinase were present at significantly higher levels in neovascular membranes than in normal retinas. The pro forms of the matrix metalloproteinases (MMP) MMP-2 and MMP-9 were significantly elevated in the neovascular membranes in comparison with levels in normal retinas. In addition, the active forms of these enzymes were present in the membranes, whereas there was no detectable level of the active forms in normal retinas.
CONCLUSIONS: Human diabetic neovascular membranes contain high levels of urokinase and MMP. The increased activity of proteinases in the final common pathway of retinal neovascularization indicates that inhibition of these enzymes may be a useful therapeutic target as an alternative approach in the management of proliferative retinopathies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067990

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Fibrillin and the eye.

Authors:  J L Ashworth; C M Kielty; D McLeod
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

3.  Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes.

Authors:  J L Barth; Y Yu; W Song; K Lu; A Dashti; Y Huang; W S Argraves; T J Lyons
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

4.  [Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model].

Authors:  J Beutel; M Lüke; K-U Bartz-Schmidt; S Grisanti
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

Review 5.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

6.  Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.

Authors:  Sirpa Loukovaara; Kaisa Lehti; Alexandra Robciuc; Timo Pessi; Juha M Holopainen; Katri Koli; Ilkka Immonen; Jorma Keski-Oja
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

7.  Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.

Authors:  Anupam Basu; Gina Menicucci; Joann Maestas; Arup Das; Paul McGuire
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

8.  The anti-angiogenic effect of chlorogenic acid on choroidal neovascularization.

Authors:  Cinoo Kim; Hyeong Gon Yu; Joonhong Sohn
Journal:  Korean J Ophthalmol       Date:  2010-06-05

9.  Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Lab Invest       Date:  2010-05-17       Impact factor: 5.662

10.  Matrix metalloproteinase-9 and vascular endothelial growth factor expression change in experimental retinal neovascularization.

Authors:  Yu Di; Qing-Zhu Nie; Xiao-Long Chen
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.